TY - JOUR
T1 - Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype
AU - Saito, Kazuyuki
AU - Toru, Shuta
AU - Shima, Sayuri
AU - Mutoh, Tatsuro
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/9
Y1 - 2018/9
N2 - We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases.
AB - We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases.
UR - http://www.scopus.com/inward/record.url?scp=85049443438&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049443438&partnerID=8YFLogxK
U2 - 10.1016/j.clineuro.2018.06.046
DO - 10.1016/j.clineuro.2018.06.046
M3 - Article
C2 - 29986202
AN - SCOPUS:85049443438
SN - 0303-8467
VL - 172
SP - 90
EP - 92
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
ER -